Quynh-thu Le MD, FACR, FASTRO

Quynh-Thu Le, MD received both her medical school and radiation oncology training at the University of California, San Francisco (UCSF). She then joined the Stanford faculty in 1997. She became the Chair of the Stanford Radiation Oncology Department in September 2011. She also holds the Katharine Dexter McCormick & Stanley Memorial Professorship at Stanford University. Her research focuses on translating laboratory findings to the clinic and vice versa in head and neck cancer (HNC), specifically in the area of tumor hypoxia and salivary gland stem cells. Her research is reflected in both her publications and grant funding. Hers was one of the first groups that identified circulating biomarkers for tumor hypoxia in HNC, leading to the application of some of these markers in clinical trials, testing hypoxia targeted strategies. On the clinical side, she has led multicenter phase II and III clinical trials, testing the addition of novel drugs as either radiosensitizer or radioprotector with chemoradiotherapy in HNC.

She has received grant support from the American Society of Clinical Oncology (ASCO), the American Society of Therapeutic Radiology and Oncology (ASTRO) Education & Development Award, R01 and R21 grants from the National Institute of Health (NIH). She was inducted into the Fellowship of the American College of Radiology (FACR), the American Society of Therapeutic Radiology and Oncology (FASTRO) and the Institute of Medicine (IOM). She’s also received a distinguished alumni award from Caltech. Administratively, she is the Co-Director of the Radiation Biology Program of the Stanford Cancer Institute and the Chair of the Head and Neck Cancer Committee of the NRG Oncology Group, which is part of the NCI supported National Clinical Trial Network (NCTN), running large phase II-III studies for radiation in solid cancers. She serves on the editorial board of the several cancer related journals.